Limin Wang, Ph.D.
- Center for Cancer Research
- National Cancer Institute
- Building 37, Room 3044
- Bethesda, MD 20892
- 240-760-7803
- limin.wang@nih.gov
RESEARCH SUMMARY
Dr. Limin Wang is the Facility Manager of the Pan-Microbial Serology Facility (PMSF) that is part of the Center for Cancer Research (CCR) at the National Cancer Institute (NCI). The PMSF focuses on determining individualized pan-microbial immune profiles associated with human diseases including immunological disorders such as cancer by providing a standardized intramural technological portal. Dr. Limin Wang uses multidisciplinary techniques, including genetic, genomic, metabolomic, immunological/viromic and single cell approaches to study carcinogenesis and biology of liver cancer. His research interests and goal are: 1) translational studies aimed at developing biomarkers for liver cancer early diagnosis and precision medicine, 2) basic studies aimed at identifying novel therapeutic targets by uncovering molecular mechanisms of liver cancer carcinogenesis and its resistance to treatment.
Areas of Expertise
Biography
Limin Wang, Ph.D.
Dr. Limin Wang obtained his Ph.D. degree in Cell Biology from Wuhan University, China. During graduate research he studied the roles of G-proteins in actin cytoskeletal reorganization and cell migration in the laboratory of Dr. Xin-Yun Huang in the Department of Physiology and Biophysics at Weill Medical College of Cornell University. He then applied his expertise on G-proteins and antibodies through leading a team to develop a series of innovative G-proteins activation and oncogene detection tool kits in a biotech company. To purse his interest in cancer research, Dr. Wang moved to NIH for postdoctoral training. He joined the Laboratory of Human Carcinogenesis at NCI as a postdoctoral fellow in 2016 and was promoted to a staff scientist in 2021. Dr. Wang’s career vision is to identify novel therapeutic targets and develop early diagnostic biomarkers of liver cancer.